Aortic Valve Stenosis Clinical Trial
| Verified date | February 2018 |
| Source | Tel-Aviv Sourasky Medical Center |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Many patients we encounter a month post TAVI, still complain of having symptoms limiting
their daily activity. The investigators set out to study whether rehabilitation strategy
early after the procedure contributes to reduction of the physical disability these patients
suffer from.
Cardiac rehabilitation (CR) is a well-established treatment in patients who underwent cardiac
surgery. Patients after TAVI, are natural candidates for referral to exercise-based CR.
Despite this, until 2013 no data have been available about the safety and the efficacy of a
comprehensive rehabilitative period in these subjects. CR is a helpful tool to maintain
independency for daily life activities and participation in socio-cultural life. despite
these differences, both patient groups did benefit in the same way from a post-acute
in-patient rehabilitation program as assessed by 6-Minute Walking Tests and FIM scores.
Patients who were unable to walk and those were slow walkers at baseline experienced an
improvement in functional status after TAVI, whereas the fast walkers did not improve and
actually experienced a modest decrease in 6MWTD.It has been shown that patients referred for
rehabilitation after TAVI are often very frail, with a high grade of functional impairment,
dependence on others and high risk of clinical complications. During a rehabilitation
program, based on a multidimensional assessment and intervention, most patients showed
significant improvement in functional status, quality of life, and autonomy, which remained
stable in the majority of subjects during mid-term follow-up.
To the investigators knowledge, no prospective study compared rehabilitation strategy to
conservative treatment after TAVI. the investigators set off to test the investigators
hypothesize that CR may help in the short and long term prognosis of these patients.
| Status | Withdrawn |
| Enrollment | 0 |
| Est. completion date | July 24, 2017 |
| Est. primary completion date | July 23, 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 75 Years and older |
| Eligibility |
Inclusion Criteria: - All TAVI patients above the age of 75 - male or female - undergoing the TAVI procedure between 1 March 2016 - 1 March 2017 - signed informed consent. Exclusion Criteria: - Unstable clinical condition - according to treating physician. - Handicap before the procedure. - Severe cognitive decline. |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Tel-Aviv Sourasky Medical Center |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | quality of life questionnaire | 3 months | ||
| Primary | 6 min walk test | number of meters the patient walked for 6 minutes to test the physical performance by the patient. | 3 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03186339 -
Validation of the "TASQ" in Patients Undergoing SAVR or TF-TAVI
|
||
| Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
| Terminated |
NCT02854319 -
REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System
|
N/A | |
| Recruiting |
NCT05601453 -
The ReTAVI Prospective Observational Registry
|
||
| Withdrawn |
NCT05481814 -
CPX in Paradoxical Low Flow Aortic Stenosis
|
||
| Completed |
NCT02241109 -
Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity
|
N/A | |
| Completed |
NCT01700439 -
Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment Surgical Aortic Valve
|
N/A | |
| Recruiting |
NCT04429035 -
SLOW-Slower Progress of caLcificatiOn With Vitamin K2
|
N/A | |
| Completed |
NCT04103931 -
Impact of a Patient Decision Aid for Treatment of Aortic Stenosis
|
N/A | |
| Completed |
NCT03950440 -
Assessing the Incidence of Postoperative Delirium Following Aortic Valve Replacement
|
||
| Active, not recruiting |
NCT02661451 -
Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
|
N/A | |
| Completed |
NCT02847546 -
Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation
|
N/A | |
| Completed |
NCT02792452 -
Clinical Value of Stress Echocardiography in Moderate Aortic Stenosis
|
||
| Completed |
NCT02758964 -
Evaluation of Cerebral Thrombembolism After TAVR
|
||
| Not yet recruiting |
NCT02536703 -
Safety and Efficacy of Lotus Valve For TAVI In Patients With Severe Aortic Stenosis In Chinese Population
|
Phase 3 | |
| Not yet recruiting |
NCT02541877 -
Sizing-sTrategy of Bicuspid AoRtic Valve Stenosis With Transcatheter Self-expandable Valve
|
Phase 3 | |
| Completed |
NCT02249000 -
BIOVALVE - I / II Clincial Investigation
|
N/A | |
| Not yet recruiting |
NCT02221921 -
Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI
|
N/A | |
| Active, not recruiting |
NCT02080299 -
Protection by Remote Ischemic Preconditioning During Transcatheter Aortic Valve Implantation
|
Phase 2 | |
| Terminated |
NCT01939678 -
Characterization and Role of Mutations in Sodium-phosphate Cotransporters in Patients With Calcific Aortic Valve Disease
|